Cystatin C: an improved estimator of glomerular filtration rate?
OF Laterza, CP Price, MG Scott - Clinical chemistry, 2002 - academic.oup.com
Background: Glomerular filtration rate (GFR) is routinely assessed by measuring the
concentrations of endogenous serum markers such as blood urea nitrogen and serum …
concentrations of endogenous serum markers such as blood urea nitrogen and serum …
[HTML][HTML] Existing and emerging technologies for point-of-care testing
A St John, CP Price - The Clinical Biochemist Reviews, 2014 - ncbi.nlm.nih.gov
The volume of point-of-care testing (PoCT) has steadily increased over the 40 or so years
since its widespread introduction. That growth is likely to continue, driven by changes in …
since its widespread introduction. That growth is likely to continue, driven by changes in …
General principles of pharmaceutical solid polymorphism: a supramolecular perspective.
B Rodriguez-Spong, CP Price… - … drug delivery reviews, 2004 - europepmc.org
The diversity of solid-state forms that an active pharmaceutical ingredient (API) may attain
relies on the repertoire of non-covalent interactions and molecular assemblies, the range of …
relies on the repertoire of non-covalent interactions and molecular assemblies, the range of …
Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine
DJ Newman, H Thakkar, RG Edwards, M Wilkie… - Kidney international, 1995 - Elsevier
Serum cystatin C measured by automated immunoassay: A more sensitive marker of
changes in GFR than serum creatinine. Serum cystatin C has been suggested as a new …
changes in GFR than serum creatinine. Serum cystatin C has been suggested as a new …
Circulating MMP9, vitamin D and variation in the TIMP‐1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders?
Background: Vitamin‐D deficiency and vitamin‐D receptor genotype (VDR) are risk factors
for several disorders with inflammatory components, including coronary heart disease …
for several disorders with inflammatory components, including coronary heart disease …
Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II)
H Finney, DJ Newman, W Gruber, P Merle… - Clinical …, 1997 - academic.oup.com
Serum cystatin C has been suggested as a new marker of glomerular filtration rate (GFR).
We describe a fully automated and rapid particle-enhanced nephelometric immunoassay …
We describe a fully automated and rapid particle-enhanced nephelometric immunoassay …
B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy
S Vickery, CP Price, RI John, NA Abbas… - American journal of …, 2005 - Elsevier
Background: Most patients with chronic kidney disease (CKD) develop cardiovascular
complications. Natriuretic peptides are novel markers that can be used to identify and …
complications. Natriuretic peptides are novel markers that can be used to identify and …
Point of care testing
CP Price - Bmj, 2001 - bmj.com
Methods I searched the literature with Medline and Embase using the key phrases “point of
care testing,”“bedside testing,”“near patient testing,” and “extra laboratory testing.” I also …
care testing,”“bedside testing,”“near patient testing,” and “extra laboratory testing.” I also …
Use of protein: creatinine ratio measurements on random urine samples for prediction of significant proteinuria: a systematic review
CP Price, RG Newall, JC Boyd - Clinical chemistry, 2005 - academic.oup.com
Background: Proteinuria is recognized as an independent risk factor for cardiovascular and
renal disease and as a predictor of end organ damage. The reference test, a 24-h urine …
renal disease and as a predictor of end organ damage. The reference test, a 24-h urine …
Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2–10 ng/ml: systematic review and meta-analysis
OBJECTIVE:: Measurement of serum prostate-specific antigen (PSA) for the detection of
prostate cancer has poor specificity in men with PSA levels between 2 and 10ng/ml. It has …
prostate cancer has poor specificity in men with PSA levels between 2 and 10ng/ml. It has …